Evaluation of possibilities for mass screening for colorectal cancer with Hemoccult fecal blood test

Diseases of the Colon and Rectum
U CarlssonE Trell

Abstract

Data from a health survey including the Hemoccult fecal blood test, together with official cause-specific death rates, were used to assess the magnitude of a controlled trial that would be required to prove a 25 percent reduction of the mortality from colorectal cancer associated with screening. All men in three age groups in the city of Malmö, Sweden, were invited, but 46 percent did not participate in, the Hemoccult screening. One carcinoma and 89 adenomas were detected in 56 of the 2422 who did. With the risk function used in our calculation and a compliance rate of 60 percent, a study population among 45- to 69-year-olds of 605,000 is required to prove an expected 25 percent reduction of the mortality with 90 percent power. Considering the size of such a trial, we question whether a controlled trial is feasible. With known risk functions for death from all causes and death from colorectal cancer, the study population was calculated using variable statistical power, participation rate, and risk reduction. Statistical methods and computer programs are given. In addition, alternative study models to assess the benefits associated with screening are discussed.

References

Nov 1, 1977·Diseases of the Colon and Rectum·P M LynchR E Harris
Jan 1, 1972·The British Journal of Surgery·R J Heald, H E Lockhart-Mummery
Jul 1, 1971·The New England Journal of Medicine·G J DevroedeG B Stickler
Sep 18, 1967·JAMA : the Journal of the American Medical Association·D H Greegor
Jun 6, 1981·Lancet·P A FarrandsD C Britton
Jan 1, 1984·Journal of Chronic Diseases·F de WaardC Honing
Oct 1, 1981·The Australian and New Zealand Journal of Surgery·A TörnqvistL Leandoer
May 23, 1980·JAMA : the Journal of the American Medical Association·J E KurnickL Nakayama

❮ Previous
Next ❯

Citations

Nov 23, 2000·Journal of Surgical Oncology·S Ottó, S Eckhardt
May 1, 1995·Abdominal Imaging·F T Fork
Aug 1, 1993·Diseases of the Colon and Rectum·G Ekelund
Aug 3, 2010·International Journal of Colorectal Disease·Göran EkelundSophia Zackrisson
Jun 1, 1990·Controlled Clinical Trials·L S Freedman
Jan 1, 1990·Journal of Clinical Epidemiology·H Straatman, A L Verbeek
Jan 1, 1989·Seminars in Surgical Oncology·G H Lytle
Mar 21, 2006·Acta Oncologica·Göran R Ekelund, Lars Janzon
Nov 1, 1987·International Journal of Colorectal Disease·J Windeler, J Köbberling
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·G R Ekelund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.